Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
6,512 results
- Utilization of Confocal Microscopy During Cardiac Surgery: Complete Statistical AnalysisIndependent statistical analysis of Utilization of Confocal Microscopy During Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03189134).
- Utilization of Hepatitis C Positive Kidneys in Negative Recipients: Complete Statistical AnalysisIndependent statistical analysis of Utilization of Hepatitis C Positive Kidneys in Negative Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03801707).
- UVIndependent statistical analysis of Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028): Complete Statistical AnalysisIndependent statistical analysis of V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- VA CARDSIndependent statistical analysis of Coronary Artery Revascularization in Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00326196).
- VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIV: Complete Statistical AnalysisIndependent statistical analysis of VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01158157).
- VAC071: A Study to Assess Efficacy of the ChAd63/MVA PvDBP Vaccines: Complete Statistical AnalysisIndependent statistical analysis of VAC071: A Study to Assess Efficacy of the ChAd63/MVA PvDBP Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00070070).
- Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001): Complete Statistical AnalysisIndependent statistical analysis of Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02269423).
- Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03189446).
- Vaginal Cuff Dehiscence and Thermal Injury During TLH: Complete Statistical AnalysisIndependent statistical analysis of Vaginal Cuff Dehiscence and Thermal Injury During TLH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02080546).
- Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse: Complete Statistical AnalysisIndependent statistical analysis of Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Vagus Nerve Stimulation for Management of Bronchoconstriction in Patients Hospitalized With COPD Exacerbations: Complete Statistical AnalysisIndependent statistical analysis of Vagus Nerve Stimulation for Management of Bronchoconstriction in Patients Hospitalized With COPD Exacerbations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Validation of a Food Frequency Questionnaire: Complete Statistical AnalysisIndependent statistical analysis of Validation of a Food Frequency Questionnaire: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03138330).
- Validation of Falls Decision Rule to Exclude Intracranial Bleeding in Geriatric Fall Patients: Complete Statistical AnalysisIndependent statistical analysis of Validation of Falls Decision Rule to Exclude Intracranial Bleeding in Geriatric Fall Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q): Complete Statistical AnalysisIndependent statistical analysis of Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Validation of the Masimo INVSENSOR00063 in Febrile and Afebrile Subejcts: Complete Statistical AnalysisIndependent statistical analysis of Validation of the Masimo INVSENSOR00063 in Febrile and Afebrile Subejcts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05787782).
- Validation of the Performance of the Electrocardiogram (ECG) Function in the Masimo INVSENSOR00057: Complete Statistical AnalysisIndependent statistical analysis of Validation of the Performance of the Electrocardiogram (ECG) Function in the Masimo INVSENSOR00057: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy – Single Arm, Multicenter, and Open-label Study: Complete Statistical AnalysisIndependent statistical analysis of Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study: primary endpoint results, effect estimate with…
- Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma: Complete Statistical AnalysisIndependent statistical analysis of Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Value of Technology to Transfer Discharge Information: Complete Statistical AnalysisIndependent statistical analysis of Value of Technology to Transfer Discharge Information: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00101868).
- Vanguard TKA With KneeAlign 2 and Without KneeAlign 2: Complete Statistical AnalysisIndependent statistical analysis of Vanguard TKA With KneeAlign 2 and Without KneeAlign 2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02695329).
- VARSUDIndependent statistical analysis of Varenicline and Motivational Advice for Smokers With Substance Use Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00756275).
- VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination: Complete Statistical AnalysisIndependent statistical analysis of VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05570630).
- VAXCHORA Pediatric Study to Assess Safety and Immunogenicity: Complete Statistical AnalysisIndependent statistical analysis of VAXCHORA Pediatric Study to Assess Safety and Immunogenicity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03220737).
- VB-111 in Surgically Accessible Recurrent/Progressive GBM: Complete Statistical AnalysisIndependent statistical analysis of VB-111 in Surgically Accessible Recurrent/Progressive GBM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04406272).
- VECTORIndependent statistical analysis of Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- VEGAIndependent statistical analysis of Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02396316).
- Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas: Complete Statistical AnalysisIndependent statistical analysis of Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- VELVETIndependent statistical analysis of A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor…
- Vemurafenib and TIL Therapy for Metastatic Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Vemurafenib and TIL Therapy for Metastatic Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02354690).
- VERDICTIndependent statistical analysis of Veterans Response to Dosage in Chiropractic Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04087291).
- VERITASIndependent statistical analysis of A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal…
- VERITASIndependent statistical analysis of Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary: primary endpoint…
- VERITASIndependent statistical analysis of Value of Multiple Modalities Using the Spectra WaveWriter Spinal Cord Stimulator System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Vertebral Body Tethering Outcomes for Pediatric Idiopathic Scoliosis: Complete Statistical AnalysisIndependent statistical analysis of Vertebral Body Tethering Outcomes for Pediatric Idiopathic Scoliosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03194568).
- VERVEIndependent statistical analysis of Virtual-reality and Emotion Regulation in Violence-Exposed Youth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05022550).
- Vessel Sparing Prostate Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Vessel Sparing Prostate Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02958787).
- Vestibular Stimulation in Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Vestibular Stimulation in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02703844).
- VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2: Complete Statistical AnalysisIndependent statistical analysis of VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative…
- VIBRANTIndependent statistical analysis of Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO): primary endpoint results, effect estimate with confidence…
- VICTASIndependent statistical analysis of Vitamin C, Thiamine, and Steroids in Sepsis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03509350).